⚕ GalenOps CRO console
← 701 (USA)

701-1415

completed
Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. Phase II · Site: 701 (USA) (Dr. Reyes) · consented 2013-09-23
Adverse events
6
Serious AEs
0
Open data queries
0
Luna dropout signal
–

Adverse events

mild assessed 2026-08-18

Mild DIARRHOEA — outcome: RECOVERED/RESOLVED; onset 2014-03-09 (study day 168.0); relationship: NONE

mild assessed 2026-08-18

Mild MICTURITION URGENCY — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-12-02 (study day 71.0); relationship: NONE

mild assessed 2026-08-18

Mild UPPER RESPIRATORY TRACT INFECTION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-10-21 (study day 29.0); relationship: NONE

mild assessed 2026-08-18

Mild UPPER RESPIRATORY TRACT INFECTION — outcome: RECOVERED/RESOLVED; onset 2013-10-21 (study day 29.0); relationship: NONE

mild assessed 2026-08-18

Mild UPPER RESPIRATORY TRACT INFECTION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-01-21 (study day 121.0); relationship: REMOTE

mild assessed 2026-08-18

Mild UPPER RESPIRATORY TRACT INFECTION — outcome: RECOVERED/RESOLVED; onset 2014-01-21 (study day 121.0); relationship: REMOTE

Data queries

No data queries.

☾ Luna engagement

This participant doesn't use Luna.